The Unit for the Evaluation of Medicines for Human Use is responsible for: • management and follow-up of marketing authorisation applications under the centralised procedure • post-marketing maintenance and pharmacovigilance of centrally authorised medicinal products • management of Community referrals and arbitrations arising from the mutual recognition procedure • provision of support to European and international harmonisation activities of the CPMP and its working parties